|
| Status |
Public on Apr 30, 2015 |
| Title |
TM107 |
| Sample type |
RNA |
| |
|
| Source name |
ovarian cancer
|
| Organism |
Homo sapiens |
| Characteristics |
age: 51
histotype: serous
debulking: GRD
Stage: IV
grading: 3
therapy code: PT
ttr (months): 16
code ttr: 0=no relapse; 1=relapse: 1
overall survival (months): 54
code os: 0=alive; 1=dead: 1
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted with Trizol reagent and miRNeasy Mini kit (Qiagen) according to manufacture's instructions.
|
| Label |
biotin
|
| Label protocol |
Biotinylated cDNA was prepared from 750ng of total RNA following miRNA DASL assay protocol provided by Illumina.
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Data processing |
The data were processed and normalised using quantile normalisation with BeadStudio software
|
| |
|
| Submission date |
Apr 13, 2015 |
| Last update date |
Apr 30, 2015 |
| Contact name |
Loris De Cecco |
| E-mail(s) |
loris.dececco@istitutotumori.mi.it
|
| Organization name |
IRCSS Istituto Nazionale Tumori
|
| Street address |
via Venezian 1
|
| City |
Milan |
| ZIP/Postal code |
20133 |
| Country |
Italy |
| |
|
| Platform ID |
GPL8179 |
| Series (2) |
| GSE25204 |
microRNA alterations associated to clinical response in advanced stage ovarian cancer patients |
| GSE67819 |
microRNA alterations associated to early relapse in advanced stage ovarian cancer patients (validation set) |
|
